Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy ...

intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from eight months to 16 months. This is a deadly disease with very ...

A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from ...

intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from eight months to 16 months. “This is a deadly disease with ...

By administering high doses of intravenous Vitamin C, researchers were able to extend the average prognosis from 8 months to ...

High-dose intravenous vitamin C doubles survival in metastatic pancreatic cancer, extending life without added toxicity or ...